Table 11.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Heart Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		2,297	2,340	2,363	2,343	2,293	2,348	2,188	2,199	2,202	2,155
Tx With Follow-up Immunosuppression Info		1,913	1,918	1,914	1,930	1,885	1,964	1,768	1,802	1,849	1,802
Corticosteroids	Category Usage	95.9%	90.3%	90.8%	89.0%	87.7%	90.3%	93.0%	92.6%	90.9%	88.3%
	Steroids	95.9%	90.3%	90.8%	89.0%	87.7%	90.3%	93.0%	92.6%	90.9%	88.3%
Cyclosporine	Category Usage	98.2%	89.6%	82.3%	85.0%	82.9%	78.5%	81.3%	77.1%	63.9%	56.7%
	Cyclosporin	96.9%	81.7%	1.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	3.6%	7.8%	42.9%	19.5%	12.3%	10.4%	7.9%	5.4%	3.4%	2.1%
	Neoral	0.3%	0.8%	42.0%	66.3%	71.4%	68.6%	73.8%	68.2%	51.2%	43.0%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	5.3%	11.3%	13.5%
	Eon	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.6%	0.6%
Tacrolimus	Category Usage	1.8%	3.5%	10.1%	15.2%	17.7%	24.6%	27.3%	30.7%	43.4%	50.2%
	FK506	1.8%	3.5%	10.1%	15.2%	17.7%	24.6%	27.3%	30.7%	43.4%	50.2%
Antimetabolites	Category Usage	96.2%	91.1%	89.4%	91.1%	90.6%	90.9%	86.8%	91.2%	89.2%	86.7%
	Azathioprine	95.0%	87.9%	76.3%	62.0%	42.7%	34.4%	28.7%	18.9%	14.6%	12.4%
	Mycophenolate mofetil	0.6%	2.9%	16.8%	32.4%	51.5%	64.3%	66.9%	79.1%	80.7%	79.6%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%
	Cytoxan	1.8%	1.7%	2.0%	1.1%	0.9%	1.0%	0.7%	0.7%	0.2%	0.1%
Other	Category Usage	0.0%	0.1%	0.0%	0.0%	0.2%	0.4%	2.1%	4.7%	7.5%	14.4%
	Rapamycin	0.0%	0.1%	0.0%	0.0%	0.2%	0.4%	2.1%	4.7%	7.5%	14.4%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.